about
Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotraumaCellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationRelevance of gap junctions and large pore channels in traumatic brain injuryInhibition of Eukaryotic Initiation Factor 2 Alpha Phosphatase Reduces Tissue Damage and Improves Learning and Memory after Experimental Traumatic Brain InjuryClinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injuryThe Effects of Shilajit on Brain Edema, Intracranial Pressure and Neurologic Outcomes following the Traumatic Brain Injury in RatProfile of minocycline neuroprotection in bilirubin-induced auditory system dysfunctionProstaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injuryAcute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotypeComparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.Traumatic brain injury: an overview of pathobiology with emphasis on military populations.The effects of cyclooxygenase inhibitors on the gastric emptying and small intestine transit in the male rats following traumatic brain injuryThe role and dynamics of β-catenin in precondition induced neuroprotection after traumatic brain injury.Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress.Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.Progesterone, administered before kainic acid, prevents decrements in cognitive performance in the Morris Water MazeErythropoietin as a neuroprotectant for neonatal brain injury: animal models.The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats.Advances in hemorrhagic stroke therapy: conventional and novel approaches.Targeting TNF-alpha receptors for neurotherapeuticsAge-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury.Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children.Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model.Mechanical membrane injury induces axonal beading through localized activation of calpainGallic acid improved behavior, brain electrophysiology, and inflammation in a rat model of traumatic brain injury.Progesterone in traumatic brain injury: time to move on to phase III trialsCalpain inhibitory flavonoids isolated from Orostachys japonicus.Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside.Stomach-specific calpain, nCL-2/calpain 8, is active without calpain regulatory subunit and oligomerizes through C2-like domains.Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury.Calpain-2 as a therapeutic target for acute neuronal injury.Cytoprotective activity of minocycline includes improvement of mitochondrial coupling: the importance of minocycline concentration and the presence of VDAC.Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse.Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast.
P2860
Q24649929-EA47D0F4-9B8E-44B1-90E1-66E9B0AE4F93Q24654460-BBCA9056-05C8-4045-8E43-D41E726453BAQ26820817-CFC8AC60-54CA-4B63-977C-A17857CCFD03Q28390392-BE616A79-FAEF-486A-8BE1-70F62193C1B2Q28390792-EA5FFD92-6733-44AC-91F1-E4CAD7FD9EF6Q28681334-E7FDF79B-B238-4687-8BC6-AE0CB3AFB2C0Q30471494-49814511-943E-46C2-9562-9A6AEB2E084DQ30570103-8E68A366-FE83-406C-8FB0-6880E13A3F24Q33532294-E005E90F-1B62-4F6E-8711-14D8028CB9B2Q33576429-86156A72-E526-425A-9064-DC16D03C961EQ33791943-230E7C2F-32EE-47FF-8953-5E2379A81772Q34065771-1D95B53F-EEF3-4ABB-9EB8-098CBF8D2E57Q35016893-07EB1113-CBC8-40D1-8D75-F9F457611E3FQ35790611-4128DC8F-C1F8-4D8E-AF3E-9EDA27F1D648Q35921561-24D49487-1173-46F6-B20F-A2993CC294E8Q35967863-36AA52C4-0F5D-4A10-A2FD-9C8E3DD6205DQ36198407-07BCB603-BD6C-4664-A71C-33E609C06B2EQ36537885-551CC65D-96B7-4BCD-A388-40F9B2AC2833Q36624171-30FA1B46-368C-42E5-977B-24E33529FFFDQ36652677-58C04DC0-5E54-4DF9-A813-E7DCB4DD1163Q36944012-AFED9892-DDA3-4548-A23F-1F36F06E7A6EQ36953319-BB97E0F4-B3C9-4AD1-B04F-8FB51D441757Q37104919-08485E73-B871-4779-A27A-511ED19D45B0Q37147796-F5B63220-7481-4087-958F-57FF1CC0DF3EQ37233036-717B7FE5-5952-4057-8E6E-74FA2BFD2889Q37354335-9EF4190E-BAAA-40C7-940F-030F522A949EQ40682483-94370A2E-8500-4A09-B024-F57E7DBE234DQ40823500-E720B5C9-43CB-41B3-AC4C-E9A459BDD8B8Q46339864-AB43C0AA-2F89-4E73-AB31-98C68C7DC4DFQ46760792-36CD3342-BF74-4481-944F-5A7C79847538Q47035960-C9C3E014-65E0-44FD-8659-8AB0428DB033Q47360067-15F07098-C119-471D-A961-2B905DB6536CQ47370941-DD6719F3-6D81-482D-B224-19A7C174649BQ47780137-B9D8D253-CECB-49C4-87B7-CE52ACA20D9EQ47880096-7C198735-C06A-4F7D-8ABB-7F095DEC6E91Q48234922-A01757D6-7DDB-43E6-AEBD-1C83FD703A9D
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Neuroprotection targets after traumatic brain injury
@ast
Neuroprotection targets after traumatic brain injury
@en
Neuroprotection targets after traumatic brain injury
@nl
type
label
Neuroprotection targets after traumatic brain injury
@ast
Neuroprotection targets after traumatic brain injury
@en
Neuroprotection targets after traumatic brain injury
@nl
prefLabel
Neuroprotection targets after traumatic brain injury
@ast
Neuroprotection targets after traumatic brain injury
@en
Neuroprotection targets after traumatic brain injury
@nl
P2093
P3181
P1476
Neuroprotection targets after traumatic brain injury
@en
P2093
Gillian Robinson
Ronald L Hayes
Stephen F Larner
P3181
P356
10.1097/WCO.0B013E3280102B10
P407
P577
2006-12-01T00:00:00Z